🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 9 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/01/1998 | 53,91 | 54,69 | 53,70 | 53,73 | -1,21% | 1,83% | 4.983.869 |
| 21/01/1998 | 54,63 | 55,02 | 53,44 | 54,39 | -1,30% | 2,89% | 6.989.531 |
| 20/01/1998 | 52,78 | 55,34 | 52,72 | 55,11 | +5,24% | 4,97% | 10.955.373 |
| 16/01/1998 | 52,21 | 52,78 | 51,88 | 52,36 | +0,98% | 1,71% | 7.687.290 |
| 15/01/1998 | 52,12 | 52,24 | 51,82 | 51,85 | -1,08% | 0,80% | 6.655.010 |
| 14/01/1998 | 50,81 | 52,48 | 50,69 | 52,42 | +3,41% | 3,52% | 10.690.438 |
| 13/01/1998 | 50,69 | 51,02 | 50,57 | 50,69 | +0,06% | 0,88% | 6.517.931 |
| 12/01/1998 | 48,66 | 50,75 | 48,37 | 50,66 | +3,22% | 4,90% | 8.138.139 |
| 09/01/1998 | 50,51 | 50,63 | 48,96 | 49,08 | -3,12% | 3,31% | 6.614.347 |
| 08/01/1998 | 49,92 | 51,02 | 49,83 | 50,66 | +1,01% | 2,39% | 5.134.362 |
| 07/01/1998 | 50,45 | 50,57 | 49,53 | 50,16 | -1,52% | 2,07% | 6.228.264 |
| 06/01/1998 | 50,78 | 51,47 | 50,75 | 50,93 | -1,39% | 1,41% | 5.057.438 |
| 05/01/1998 | 51,35 | 51,94 | 50,84 | 51,65 | +0,58% | 2,15% | 6.298.480 |
| 02/01/1998 | 50,21 | 51,44 | 50,07 | 51,35 | +1,53% | 2,73% | 4.791.666 |
| 31/12/1997 | 50,81 | 51,02 | 50,04 | 50,57 | -0,64% | 1,94% | 2.844.691 |
| 30/12/1997 | 50,10 | 51,05 | 50,01 | 50,90 | +1,85% | 2,08% | 3.103.966 |
| 29/12/1997 | 49,74 | 50,18 | 49,65 | 49,98 | +1,21% | 1,08% | 3.537.000 |
| 26/12/1997 | 48,54 | 49,38 | 48,52 | 49,38 | +2,22% | 1,78% | 1.824.358 |
| 24/12/1997 | 50,16 | 50,16 | 48,25 | 48,31 | -3,05% | 3,80% | 2.905.056 |
| 23/12/1997 | 50,27 | 50,90 | 49,77 | 49,83 | -1,42% | 2,25% | 4.495.291 |
| 22/12/1997 | 49,80 | 50,57 | 49,14 | 50,54 | +3,23% | 2,87% | 5.019.501 |
| 19/12/1997 | 49,80 | 50,18 | 48,07 | 48,96 | -2,38% | 4,25% | 9.082.806 |
| 18/12/1997 | 50,57 | 51,20 | 49,80 | 50,16 | -2,04% | 2,77% | 6.270.603 |
| 17/12/1997 | 51,14 | 51,47 | 50,33 | 51,20 | +0,59% | 2,22% | 6.580.811 |
| 16/12/1997 | 50,42 | 51,14 | 50,18 | 50,90 | +1,13% | 1,89% | 5.079.446 |
| 15/12/1997 | 49,86 | 51,17 | 49,65 | 50,33 | +0,72% | 3,05% | 4.907.784 |
| 12/12/1997 | 50,01 | 50,07 | 49,05 | 49,98 | +0,12% | 2,03% | 4.483.344 |
| 11/12/1997 | 49,62 | 50,69 | 49,50 | 49,92 | -0,24% | 2,40% | 6.820.594 |
| 10/12/1997 | 49,74 | 50,16 | 49,20 | 50,04 | -0,18% | 1,92% | 6.314.200 |
| 09/12/1997 | 49,71 | 50,63 | 49,56 | 50,13 | +0,30% | 2,16% | 7.896.890 |